Title: Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
Journal: Head & neck20120801
Title: Distinct effects of cevimeline and pilocarpine on salivary mechanisms, cardiovascular response and thirst sensation in rats.
Journal: Archives of oral biology20120401
Title: Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
Journal: Ophthalmology20110701
Title: Abnormal subcellular localization of AQP5 and downregulated AQP5 protein in parotid glands of streptozotocin-induced diabetic rats.
Journal: Biochimica et biophysica acta20110501
Title: Cevimeline-induced monophasic salivation from the mouse submandibular gland: decreased Na+ content in saliva results from specific and early activation of Na+/H+ exchange.
Journal: The Journal of pharmacology and experimental therapeutics20110401
Title: Cevimeline (Evoxac ®) overdose.
Journal: Journal of medical toxicology : official journal of the American College of Medical Toxicology20110301
Title: New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Journal: Clinical and experimental immunology20101001
Title: The relationship between the drug concentration profiles in plasma and the drug doses in the colon.
Journal: Chemical & pharmaceutical bulletin20101001
Title: Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
Journal: International journal of pharmaceutics20100104
Title: Comparison of the effects of pilocarpine and cevimeline on salivary flow.
Journal: International journal of dental hygiene20090501
Title: Identification of aquaporin-5 and lipid rafts in human resting saliva and their release into cevimeline-stimulated saliva.
Journal: Biochimica et biophysica acta20090101
Title: Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Journal: Modern rheumatology20090101
Title: Cevimeline enhances the excitability of rat superior salivatory neurons.
Journal: The journal of medical investigation : JMI20090101
Title: Correlation between salivary secretion and salivary AQP5 levels in health and disease.
Journal: The journal of medical investigation : JMI20090101
Title: Effects of pilocarpine and cevimeline on Ca2+ mobilization in rat parotid acini and ducts.
Journal: The journal of medical investigation : JMI20090101
Title: Effects of cevimeline on the immunolocalization of aquaporin-5 and the ultrastructure of salivary glands in Sjögren's syndrome model mice.
Journal: The Kurume medical journal20090101
Title: Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome.
Journal: The Journal of rheumatology20081101
Title: Degradation of submandibular gland AQP5 by parasympathetic denervation of chorda tympani and its recovery by cevimeline, an M3 muscarinic receptor agonist.
Journal: American journal of physiology. Gastrointestinal and liver physiology20080701
Title: The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Journal: Clinical rheumatology20080401
Title: Cevimeline.
Journal: Drugs20080101
Title: Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
Journal: International journal of radiation oncology, biology, physics20071201
Title: Xerostomia: causes and treatment.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists20071201
Title: Effect of a muscarinic M3 receptor agonist on gastric motility.
Journal: Journal of gastroenterology and hepatology20071101
Title: Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
Journal: Clinical rheumatology20070801
Title: Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Journal: International journal of radiation oncology, biology, physics20070715
Title: Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice.
Journal: The Bulletin of Tokyo Dental College20070501
Title: Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics20070301
Title: [Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Recommendations for supportive therapy for Sjögren's syndrome].
Journal: Zeitschrift fur Rheumatologie20070201
Title: Effects of cevimeline on salivation and thirst in conscious rats.
Journal: Archives of oral biology20070101
Title: Unraveling the mysteries of saliva: its importance in maintaining oral health. Transcript of a lecture presented on August 6 at the 2006 AGD Annual Meeting & Exposition.
Journal: General dentistry20070101
Title: The therapy of Sjogren's syndrome: a review.
Journal: La Clinica terapeutica20070101
Title: Cevimeline reduced mouth dryness and increased salivary flow in patients with xerostomia complicating chronic graft-versus-host disease.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation20060701
Title: New approaches to preventing xerostomia.
Journal: The journal of supportive oncology20060201
Title: Cevimeline hydrochloride improved cholinergic dysfunction in a patient with pure autonomic failure.
Journal: Journal of neurology20060101
Title: Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
Journal: Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry20060101
Title: Management of xerostomia related to radiotherapy for head and neck cancer.
Journal: Oncology (Williston Park, N.Y.)20051201
Title: Identification of AQP5 in lipid rafts and its translocation to apical membranes by activation of M3 mAChRs in interlobular ducts of rat parotid gland.
Journal: American journal of physiology. Cell physiology20051101
Title: Idiopathic CD4+ lymphocytopenia and Sjogren syndrome.
Journal: Archives of ophthalmology (Chicago, Ill. : 1960)20050701
Title: Effect of cevimeline on salivary components in patients with Sjögren syndrome.
Journal: Pharmacology20050501
Title: Salivary hypofunction and xerostomia: diagnosis and treatment.
Journal: Dental clinics of North America20050401
Title: Dentistry. Implications and management of xerostomia in the HIV patient.
Journal: HIV clinician20050101
Title: Dentistry. Clinic assesses effect of medication on dry mouth syndrome.
Journal: HIV clinician20050101
Title: Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Journal: Drugs & aging20050101
Title: [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
Journal: Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology20041001
Title: Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
Journal: American journal of ophthalmology20040701
Title: [Future therapy strategies for salivary gland impairment].
Journal: Refu'at ha-peh veha-shinayim (1993)20040701
Title: Cevimeline gargle for the treatment of xerostomia in patients with Sjögren's syndrome.
Journal: Annals of the rheumatic diseases20040601
Title: [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
Journal: Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology20040401
Title: Radiation-induced xerostomia: how dry is your patient?
Journal: Clinical journal of oncology nursing20040201
Title: Ligand-selective signaling and high-content screening for GPCR drugs.
Journal: Drug discovery today20031215
Title: Reduction in distractibility with AF102B and THA in the macaque.
Journal: Pharmacology, biochemistry, and behavior20030901
Title: Age-related decreases in the response of aquaporin-5 to acetylcholine in rat parotid glands.
Journal: Journal of dental research20030601
Title: Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer20030401
Title: Effect of SNI-2011 on amylase secretion from parotid tissue in rats and in neuronal nitric oxide synthase knockout mice.
Journal: European journal of pharmacology20030319
Title: Pharmacokinetics and metabolism of the novel muscarinic receptor agonist SNI-2011 in rats and dogs.
Journal: Arzneimittel-Forschung20030101
Title: Pharmacokinetics and metabolism of radiolabelled SNI-2011, a novel muscarinic receptor agonist, in healthy volunteers. Comprehensive understanding of absorption, metabolism and excretion using radiolabelled SNI-2011.
Journal: Arzneimittel-Forschung20030101
Title: Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Journal: Arzneimittel-Forschung20030101
Title: M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
Journal: Journal of molecular neuroscience : MN20030101
Title: [Cevimeline hydrochloride hydrate (Saligren capsule 30 mg): a review of its pharmacological profiles and clinical potential in xerostomia].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20021001
Title: Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Journal: Archives of internal medicine20020610
Title: Assessing salivary gland hypofunction--Part two.
Journal: Practical procedures & aesthetic dentistry : PPAD20020401
Title: A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Journal: Arthritis and rheumatism20020301
Title: General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
Journal: Arzneimittel-Forschung20020101
Title: General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
Journal: Arzneimittel-Forschung20020101
Title: General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 3rd communication: effects on respiratory and cardiovascular systems.
Journal: Arzneimittel-Forschung20020101
Title: General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
Journal: Arzneimittel-Forschung20020101
Title: Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome.
Journal: Advances in experimental medicine and biology20020101
Title: Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Journal: Clinical immunology (Orlando, Fla.)20011201
Title: Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011.
Journal: Biological & pharmaceutical bulletin20011101
Title: Salivary enhancement: current status and future therapies.
Journal: Journal of dental education20011001
Title: Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists.
Journal: Brain research20010629
Title: A new medication for treatment of dry mouth in Sjögren's syndrome.
Journal: Texas dental journal20010401
Title: New drug approvals in 2000.
Journal: General dentistry20010101
Title: AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices.
Journal: European journal of pharmacology19920910
Title: Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia.
Journal: Brain research19900115
Title: Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
Journal: Japanese journal of pharmacology19881201
Title: Ono K, et al. Distinct effects of cevimeline and pilocarpine on salivary mechanisms, cardiovascular response and thirst sensation in rats.Arch Oral Biol. 2012 Apr;57(4):421-8. Epub 2011 Nov 17.
Title: Witsell DL, et al. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.Head Neck. 2012 Aug;34(8):1136-42. doi: 10.1002/hed.21894. Epub 2012 Jan 9.
Title: Kondo Y, et al.Cevimeline-induced monophasic salivation from the mouse submandibular gland: decreased Na+ content in saliva results from specific and early activation of Na+/H+ exchange.J Pharmacol Exp Ther. 2011 Apr;337(1):267-74. Epub 2011 Jan 14.
Title: Voskoboynik B, et al.Cevimeline (Evoxac) overdose.J Med Toxicol. 2011 Mar;7(1):57-9.
Title: Mitoh Y, et al. Effects of cevimeline on excitability of parasympathetic preganglionic neurons in the superior salivatory nucleus of rats. Auton Neurosci. 2017 Sep;206:1-7.
